Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Meta misled users about its products’ safety, jury decides

March 24, 2026

RR SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Richtech Robotics (RR) Investors of Securities Class Action Deadline on April 3, 2026

March 24, 2026

Payden & Rygel Receives 2026 LSEG Lipper Fund Award for The Payden California Municipal Social Impact Fund (PYCRX) As the Best California Intermediate Municipal Debt Fund Over Three, Five, and Ten Years

March 24, 2026

Gelatide Liquid Drops Enter the U.S. Market: A New Approach to Metabolic Optimization and Adaptogenic Support

March 24, 2026

As Dairy Gains National Momentum, Wisconsin Dairy Farmers Roll Out on City Buses

March 24, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Home Infusion Therapy Market Poised for Expansion: Comprehensive Analysis Forecasts Strong Growth by 2033
Press Release

Home Infusion Therapy Market Poised for Expansion: Comprehensive Analysis Forecasts Strong Growth by 2033

By News RoomJanuary 31, 20243 Mins Read
Home Infusion Therapy Market Poised for Expansion: Comprehensive Analysis Forecasts Strong Growth by 2033
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) — The “Global Home Infusion Therapy Market Analysis & Forecast to 2023-2033: Market By Product; By Application; By End-user; and By Region” report has been added to ResearchAndMarkets.com’s offering.

As health care trends shift towards in-home patient care, the market is progressively adapting, seeing an increase in innovative partnerships among market players to enhance technology and patient care in the comfort of their own homes.

The market analysis offers a segmented view, breaking down data into various sub-categories such as product-based infusion pumps, which are leading revenue generation. The demand for such pumps is growing in line with advancements in the technology of remote monitoring through devices like IV Ensure, which significantly improve patient outcomes through adherence and well-being tracking

From an application perspective, anti-infective therapy has topped the market, supported by heightened awareness and increased prevalence of infectious diseases. On the other hand, chemotherapy is expected to experience the fastest growth rate, propelled by technological advancements and the rising incidence of chronic diseases. An example of innovation in this space includes the AutoEx® Chemotherapy Infusion Pump, which recently received marketing approval from the NMPA.

As for end-users, patients themselves have contributed vastly to the market’s profits. Home infusion therapy has been embraced due to its convenience, independence it offers to patients, and prevention of hospital-acquired infections. The AvosetGO is a case in point, with built-in touch screens on infusion pump apparatuses, allowing for remote monitoring.

The comprehensive report also provides a deep-dive regional analysis where North America is reported as a dominant force in the global market due to rising chronic diseases and technological breakthroughs in home infusion therapy. Collaborations such as the partnership between Ivenix, Inc. and Smiths Medical highlight the regional market’s commitment to advancing patient safety.

Asia Pacific, however, is anticipated to witness the fastest growth rate, guided by a strong inclination towards in-home care and advancements in healthcare. Significant partnerships such as the one between Terumo and Glooko aim to introduce world-class diabetes data solutions, thereby illustrating the innovative trajectory of APAC’s healthcare industry.

Key Attributes:

Report Attribute Details
No. of Pages 145
Forecast Period 2022 – 2033
Estimated Market Value (USD) in 2022 $23.35 Billion
Forecasted Market Value (USD) by 2033 $51.3 Billion
Compound Annual Growth Rate 7.4%
Regions Covered Global

Companies Mentioned

  • CareCentrix Inc.
  • Fresenius Kabi
  • B. Braun Melsungen AG
  • ICU Medical Inc.
  • Nipro Corporation
  • Becton Dickinson and Companies
  • McLaren Health Care
  • Catholic Health Initiatives
  • Smiths Medical
  • Community Surgical Supply
  • Eli Lilly and Company
  • Sutter Health
  • Terumo Corporation
  • Option Care Health Inc.
  • Baxter International
  • McKesson Medical-Surgical Inc.

Scope of the Report

  • Segmentation by Product
    • Infusion Pumps
    • IV Cannulas
    • Needleless Connectors
    • Intravenous Sets
  • Segmentation by Application
    • Hydration Therapy
    • Chemotherapy
    • Enteral Nutrition
    • Anti-infective Therapy
    • IVIg/Specialty Pharmaceuticals
    • Total Parenteral Nutrition
    • Others
  • Segmentation by End-user
    • Nurse
    • Hospitals
    • Patients
    • Others
  • Segmentation by Region
    • North America (U.S., Canada)
    • Europe (Germany, France, UK, Spain, Italy, Rest of Europe)
    • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
    • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
    • Middle East & Africa (South Africa, GCC, Rest of MEA)

For more information about this report visit https://www.researchandmarkets.com/r/8mha2u

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Home Infusion Therapy Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

RR SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Richtech Robotics (RR) Investors of Securities Class Action Deadline on April 3, 2026

Payden & Rygel Receives 2026 LSEG Lipper Fund Award for The Payden California Municipal Social Impact Fund (PYCRX) As the Best California Intermediate Municipal Debt Fund Over Three, Five, and Ten Years

Gelatide Liquid Drops Enter the U.S. Market: A New Approach to Metabolic Optimization and Adaptogenic Support

As Dairy Gains National Momentum, Wisconsin Dairy Farmers Roll Out on City Buses

PRSA‑NY Opens Submissions for 2026 Big Apple Awards, Honoring Communications Excellence Across the New York Metro Area

Thomas Global Systems’ Abrams Immersive Tactical Trainer (ITT) showcased to US Government and industry partners

Dycom Industries, Inc. Appoints Raejeanne Skillern to Board of Directors

Erdene Announces 2025 Results – Provides Bayan Khundii Gold Mine and Exploration Update

Epirus, General Dynamics Land Systems and Kodiak AI Unveil New Autonomous HPM System for Counter-UAS

Editors Picks

RR SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Richtech Robotics (RR) Investors of Securities Class Action Deadline on April 3, 2026

March 24, 2026

Payden & Rygel Receives 2026 LSEG Lipper Fund Award for The Payden California Municipal Social Impact Fund (PYCRX) As the Best California Intermediate Municipal Debt Fund Over Three, Five, and Ten Years

March 24, 2026

Gelatide Liquid Drops Enter the U.S. Market: A New Approach to Metabolic Optimization and Adaptogenic Support

March 24, 2026

As Dairy Gains National Momentum, Wisconsin Dairy Farmers Roll Out on City Buses

March 24, 2026

Latest News

PRSA‑NY Opens Submissions for 2026 Big Apple Awards, Honoring Communications Excellence Across the New York Metro Area

March 24, 2026

Thomas Global Systems’ Abrams Immersive Tactical Trainer (ITT) showcased to US Government and industry partners

March 24, 2026

Prairie Harm Reduction fires executive director, citing ‘significant’ deficit

March 24, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version